<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Axim Biotechnologies Inc — News on 6ix</title>
<link>https://6ix.com/company/axim-biotechnologies-inc</link>
<description>Latest news and press releases for Axim Biotechnologies Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 29 Jan 2026 14:10:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/axim-biotechnologies-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354a6d78dffbe2df0e4ab9.webp</url>
<title>Axim Biotechnologies Inc</title>
<link>https://6ix.com/company/axim-biotechnologies-inc</link>
</image>
<item>
<title>AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-inc-and-medical-marijuana-inc-enter-into-strategic-alliance-to-research-and-develop-applications-and-uses-of-patent-for-water-soluble-cannabinoids</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-inc-and-medical-marijuana-inc-enter-into-strategic-alliance-to-research-and-develop-applications-and-uses-of-patent-for-water-soluble-cannabinoids</guid>
<pubDate>Thu, 29 Jan 2026 14:10:00 GMT</pubDate>
<description>AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids.</description>
</item>
<item>
<title>Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/medical-marijuana-inc-and-axim-biotechnologies-inc-enter-into-strategic-alliance-to-research-and-develop-applications-and-uses-of-patent-for-water-soluble-cannabinoids</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/medical-marijuana-inc-and-axim-biotechnologies-inc-enter-into-strategic-alliance-to-research-and-develop-applications-and-uses-of-patent-for-water-soluble-cannabinoids</guid>
<pubDate>Thu, 29 Jan 2026 14:10:00 GMT</pubDate>
<description>Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids.</description>
</item>
<item>
<title>AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-engages-624-advisors-owned-and-managed-by-dr-alan-j-touch-innovator-and-global-regulatory-leader-as-chief-medical-and-regulatory-affairs-advisor</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-engages-624-advisors-owned-and-managed-by-dr-alan-j-touch-innovator-and-global-regulatory-leader-as-chief-medical-and-regulatory-affairs-advisor</guid>
<pubDate>Tue, 20 Jan 2026 14:08:00 GMT</pubDate>
<description>AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor.</description>
</item>
<item>
<title>AXIM Biotechnologies, Inc. Announces Exclusive Distribution Agreement With VisionPlus Corp. for TearScan(R) Lactoferrin and IgE Diagnostic Tests in South Korea</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-inc-announces-exclusive-distribution-agreement-with-visionplus-corp-for-tearscanr-lactoferrin-and-ige-diagnostic-tests-in-south-korea</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-inc-announces-exclusive-distribution-agreement-with-visionplus-corp-for-tearscanr-lactoferrin-and-ige-diagnostic-tests-in-south-korea</guid>
<pubDate>Thu, 23 Oct 2025 12:11:00 GMT</pubDate>
<description>AXIM Biotechnologies, Inc. Announces Exclusive Distribution Agreement With VisionPlus Corp. for TearScan(R) Lactoferrin and IgE Diagnostic Tests in South Korea.</description>
</item>
<item>
<title>AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-announces-exclusive-latin-america-license-and-distribution-agreement-with-jk-medical-for-tearscanr-ocular-diagnostic-tests</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-announces-exclusive-latin-america-license-and-distribution-agreement-with-jk-medical-for-tearscanr-ocular-diagnostic-tests</guid>
<pubDate>Tue, 07 Oct 2025 13:13:00 GMT</pubDate>
<description>AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests.</description>
</item>
<item>
<title>Axim Biotechnologies Files Pre-Submission With FDA for CLIA Waiver Pathway on Lactoferrin Point-of-Care Diagnostic Test</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-files-pre-submission-with-fda-for-clia-waiver-pathway-on-lactoferrin-point-of-care-diagnostic-test</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-files-pre-submission-with-fda-for-clia-waiver-pathway-on-lactoferrin-point-of-care-diagnostic-test</guid>
<pubDate>Tue, 24 Jun 2025 13:15:00 GMT</pubDate>
<description>Axim Biotechnologies Files Pre-Submission With FDA for CLIA Waiver Pathway on Lactoferrin Point-of-Care Diagnostic Test.</description>
</item>
<item>
<title>AXIM® Biotechnologies Receives Medical Device Manufacturing License</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-receives-medical-device-manufacturing-license</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-receives-medical-device-manufacturing-license</guid>
<pubDate>Fri, 31 May 2024 17:39:30 GMT</pubDate>
<description>AXIM® Biotechnologies Receives Medical Device Manufacturing License.</description>
</item>
<item>
<title>EQS-News: VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/eqs-news-video-axim-biotechnologies-ceo-presents-at-benzinga-virtual-healthcare-summit-2024</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/eqs-news-video-axim-biotechnologies-ceo-presents-at-benzinga-virtual-healthcare-summit-2024</guid>
<pubDate>Wed, 27 Mar 2024 13:05:22 GMT</pubDate>
<description>EQS-News: VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024.</description>
</item>
<item>
<title>VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/video-axim-biotechnologies-ceo-presents-at-benzinga-virtual-healthcare-summit-2024</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/video-axim-biotechnologies-ceo-presents-at-benzinga-virtual-healthcare-summit-2024</guid>
<pubDate>Wed, 27 Mar 2024 13:02:31 GMT</pubDate>
<description>VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024.</description>
</item>
<item>
<title>EQS-News: AXIM Biotechnologies Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/eqs-news-axim-biotechnologies-tear-based-testing-platform-continues-to-gain-traction-after-successful-clinical-validation</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/eqs-news-axim-biotechnologies-tear-based-testing-platform-continues-to-gain-traction-after-successful-clinical-validation</guid>
<pubDate>Tue, 20 Feb 2024 14:06:35 GMT</pubDate>
<description>EQS-News: AXIM Biotechnologies Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation.</description>
</item>
<item>
<title>AXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-tear-based-testing-platform-continues-to-gain-traction-after-successful-clinical-validation</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-tear-based-testing-platform-continues-to-gain-traction-after-successful-clinical-validation</guid>
<pubDate>Tue, 20 Feb 2024 14:01:47 GMT</pubDate>
<description>AXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation.</description>
</item>
<item>
<title>AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-partners-with-leading-diagnostic-manufacturer-auer-precision-to-scale-assay-production</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-partners-with-leading-diagnostic-manufacturer-auer-precision-to-scale-assay-production</guid>
<pubDate>Wed, 20 Dec 2023 14:02:02 GMT</pubDate>
<description>AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production.</description>
</item>
<item>
<title>AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-develops-first-non-invasive-rapid-point-of-care-diagnostic-test-for-parkinsons-disease</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-develops-first-non-invasive-rapid-point-of-care-diagnostic-test-for-parkinsons-disease</guid>
<pubDate>Tue, 12 Sep 2023 13:05:22 GMT</pubDate>
<description>AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease.</description>
</item>
<item>
<title>AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-receives-notice-of-us-patent-allowance-for-three-separate-patents-including-its-rapid-point-of-care-neutralizing-antibody-test</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-receives-notice-of-us-patent-allowance-for-three-separate-patents-including-its-rapid-point-of-care-neutralizing-antibody-test</guid>
<pubDate>Tue, 01 Aug 2023 13:05:51 GMT</pubDate>
<description>AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test.</description>
</item>
<item>
<title>Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/update-aximr-biotechnologies-starts-shipping-revenue-generating-ige-diagnostic-validation-assays-to-customers-nationwide</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/update-aximr-biotechnologies-starts-shipping-revenue-generating-ige-diagnostic-validation-assays-to-customers-nationwide</guid>
<pubDate>Wed, 12 Jul 2023 17:36:36 GMT</pubDate>
<description>Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide.</description>
</item>
<item>
<title>AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-starts-shipping-revenue-generating-ige-diagnostic-validation-assays-to-customers-nationwide</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-starts-shipping-revenue-generating-ige-diagnostic-validation-assays-to-customers-nationwide</guid>
<pubDate>Wed, 12 Jul 2023 13:01:04 GMT</pubDate>
<description>AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide.</description>
</item>
<item>
<title>AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-announces-over-40-initial-clinic-commitments-for-its-full-diagnostic-assay-platform-launch</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/axim-biotechnologies-announces-over-40-initial-clinic-commitments-for-its-full-diagnostic-assay-platform-launch</guid>
<pubDate>Wed, 24 May 2023 13:52:44 GMT</pubDate>
<description>AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch.</description>
</item>
<item>
<title>AXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-appoints-kurt-phinney-as-chief-operating-officer-to-drive-scaling-and-optimization-of-manufacturing-unit</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-appoints-kurt-phinney-as-chief-operating-officer-to-drive-scaling-and-optimization-of-manufacturing-unit</guid>
<pubDate>Tue, 23 May 2023 13:03:55 GMT</pubDate>
<description>AXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit.</description>
</item>
<item>
<title>AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-commences-commercial-manufacturing-of-fda-cleared-proprietary-ocular-diagnostic-assays</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-commences-commercial-manufacturing-of-fda-cleared-proprietary-ocular-diagnostic-assays</guid>
<pubDate>Tue, 11 Apr 2023 13:02:08 GMT</pubDate>
<description>AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays.</description>
</item>
<item>
<title>AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing</title>
<link>https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-files-provisional-patent-on-novel-methodology-for-use-in-optical-diagnostic-assay-manufacturing</link>
<guid isPermaLink="true">https://6ix.com/company/axim-biotechnologies-inc/news/aximr-biotechnologies-files-provisional-patent-on-novel-methodology-for-use-in-optical-diagnostic-assay-manufacturing</guid>
<pubDate>Tue, 14 Mar 2023 13:01:29 GMT</pubDate>
<description>AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing.</description>
</item>
</channel>
</rss>